People

Andrew (Andy) Cochran is an associate in the Life Sciences Patent Litigation group in the firm’s Trial & Global Disputes Practice. Andy focuses his practice on intellectual property matters, including complex patent litigation matters involving pharmaceuticals, biotechnology, and biologics/biosimilars both in federal court and before the Patent Trial and Appeal Board of the U.S. Patent Office. Andy also has an extensive patent prosecution background that has encompassed an array of technologies, including automotive hybrid systems, medical devices, consumer products, and oncology.  

Andy is based in King and Spalding's New York office where he works with a team of attorneys representing life sciences companies in patent litigation involving small molecule and biologic products.  He has represented clients in matters relating to biosimilar antibody products, an oral treatment for treating rosacea, and pharmaceuticals for treating gastrointestinal disorders.  

Andy received his J.D. from Fordham University School of Law in 2013 (evening division) while working full-time as a technical adviser and patent agent at another New York law firm.  He received a M.S. in biochemistry with emphasis on biotechnology and a B.S. in microbiology with a minor in molecular genetics, both from The Ohio State University in Columbus, Ohio.  

Full Bio

Credentials

J.D., Fordham University School of Law

M.S. in Biochemistry, The Ohio State University

B.S. in Microbiology, The Ohio State University

New York

U.S. Patent and Trademark Office

New York Intellectual Property Law Association (NYIPLA)

Matters

Represented Galderma in Hatch-Waxman litigation relating to Oracea®, a once-daily doxycycline product used to treat rosacea

Represented pharmaceutical company in BPCIA litigation regarding a biosimilar to monoclonal antibody product, Humira®

Represented the patent owner in an inter partes review regarding a long-acting pharmaceutical product used to treat alcohol and opioid dependence

See more
Icon close

Close

Matters

Represented Galderma in Hatch-Waxman litigation relating to Oracea®, a once-daily doxycycline product used to treat rosacea

Represented pharmaceutical company in BPCIA litigation regarding a biosimilar to monoclonal antibody product, Humira®

Represented the patent owner in an inter partes review regarding a long-acting pharmaceutical product used to treat alcohol and opioid dependence

Represented a pharmaceutical company in Hatch-Waxman litigation involving Entereg, an oral pharmaceutical product for the treatment of post-operative ileus 

Represented a pharmaceutical company in Hatch-Waxman litigation involving an extended-release product used to treat the gastrointestinal disorder, ulcerative colitis

Matters

Represented Galderma in Hatch-Waxman litigation relating to Oracea®, a once-daily doxycycline product used to treat rosacea

Represented pharmaceutical company in BPCIA litigation regarding a biosimilar to monoclonal antibody product, Humira®

Represented the patent owner in an inter partes review regarding a long-acting pharmaceutical product used to treat alcohol and opioid dependence

See more
Icon close

Close

Matters

Represented Galderma in Hatch-Waxman litigation relating to Oracea®, a once-daily doxycycline product used to treat rosacea

Represented pharmaceutical company in BPCIA litigation regarding a biosimilar to monoclonal antibody product, Humira®

Represented the patent owner in an inter partes review regarding a long-acting pharmaceutical product used to treat alcohol and opioid dependence

Represented a pharmaceutical company in Hatch-Waxman litigation involving Entereg, an oral pharmaceutical product for the treatment of post-operative ileus 

Represented a pharmaceutical company in Hatch-Waxman litigation involving an extended-release product used to treat the gastrointestinal disorder, ulcerative colitis

Credentials

J.D., Fordham University School of Law

M.S. in Biochemistry, The Ohio State University

B.S. in Microbiology, The Ohio State University

New York

U.S. Patent and Trademark Office

New York Intellectual Property Law Association (NYIPLA)